129 related articles for article (PubMed ID: 7705221)
1. Neuronal injury associated with HIV-1 and potential treatment with calcium-channel and NMDA antagonists.
Lipton SA
Dev Neurosci; 1994; 16(3-4):145-51. PubMed ID: 7705221
[TBL] [Abstract][Full Text] [Related]
2. HIV-related neuronal injury. Potential therapeutic intervention with calcium channel antagonists and NMDA antagonists.
Lipton SA
Mol Neurobiol; 1994; 8(2-3):181-96. PubMed ID: 7999315
[TBL] [Abstract][Full Text] [Related]
3. AIDS-related dementia and calcium homeostasis.
Lipton SA
Ann N Y Acad Sci; 1994 Dec; 747():205-24. PubMed ID: 7847672
[TBL] [Abstract][Full Text] [Related]
4. Similarity of neuronal cell injury and death in AIDS dementia and focal cerebral ischemia: potential treatment with NMDA open-channel blockers and nitric oxide-related species.
Lipton SA
Brain Pathol; 1996 Oct; 6(4):507-17. PubMed ID: 8944320
[TBL] [Abstract][Full Text] [Related]
5. Update on current models of HIV-related neuronal injury: platelet-activating factor, arachidonic acid and nitric oxide.
Lipton SA; Yeh M; Dreyer EB
Adv Neuroimmunol; 1994; 4(3):181-8. PubMed ID: 7874385
[TBL] [Abstract][Full Text] [Related]
6. Neuronal injury associated with HIV-1: approaches to treatment.
Lipton SA
Annu Rev Pharmacol Toxicol; 1998; 38():159-77. PubMed ID: 9597152
[TBL] [Abstract][Full Text] [Related]
7. Models of neuronal injury in AIDS: another role for the NMDA receptor?
Lipton SA
Trends Neurosci; 1992 Mar; 15(3):75-9. PubMed ID: 1373919
[TBL] [Abstract][Full Text] [Related]
8. HIV-related neurotoxicity.
Lipton SA
Brain Pathol; 1991 Apr; 1(3):193-9. PubMed ID: 1669708
[TBL] [Abstract][Full Text] [Related]
9. Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases.
Yoshioka M; Bradley WG; Shapshak P; Nagano I; Stewart RV; Xin KQ; Srivastava AK; Nakamura S
Adv Neuroimmunol; 1995; 5(3):335-58. PubMed ID: 8748077
[TBL] [Abstract][Full Text] [Related]
10. Pathways to neuronal injury and apoptosis in HIV-associated dementia.
Kaul M; Garden GA; Lipton SA
Nature; 2001 Apr; 410(6831):988-94. PubMed ID: 11309629
[TBL] [Abstract][Full Text] [Related]
11. [HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system].
Merino JJ; Montes ML; Blanco A; Bustos MJ; Oreja-Guevara C; Bayon C; Cuadrado A; Lubrini G; Cambron I; Munoz A; Cebolla S; Gutierrez-Fernandez M; Bernardino JI; Arribas JR; Fiala M
Rev Neurol; 2011 Jan; 52(2):101-11. PubMed ID: 21271550
[TBL] [Abstract][Full Text] [Related]
12. Ethanol potentiates HIV-1 gp120-induced apoptosis in human neurons via both the death receptor and NMDA receptor pathways.
Chen W; Tang Z; Fortina P; Patel P; Addya S; Surrey S; Acheampong EA; Mukhtar M; Pomerantz RJ
Virology; 2005 Mar; 334(1):59-73. PubMed ID: 15749123
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
Lipton SA; Gu Z; Nakamura T
Int Rev Neurobiol; 2007; 82():1-27. PubMed ID: 17678953
[TBL] [Abstract][Full Text] [Related]
14. Laboratory basis of novel therapeutic strategies to prevent HIV-related neuronal injury.
Lipton SA
Res Publ Assoc Res Nerv Ment Dis; 1994; 72():183-202. PubMed ID: 8115713
[No Abstract] [Full Text] [Related]
15. HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: relevance for HIV-1-associated dementia.
Xiong H; Zeng YC; Lewis T; Zheng J; Persidsky Y; Gendelman HE
J Neurovirol; 2000 May; 6 Suppl 1():S14-23. PubMed ID: 10871761
[TBL] [Abstract][Full Text] [Related]
16. The chemical biology of clinically tolerated NMDA receptor antagonists.
Chen HS; Lipton SA
J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus encephalitis in SCID mice.
Persidsky Y; Limoges J; McComb R; Bock P; Baldwin T; Tyor W; Patil A; Nottet HS; Epstein L; Gelbard H; Flanagan E; Reinhard J; Pirruccello SJ; Gendelman HE
Am J Pathol; 1996 Sep; 149(3):1027-53. PubMed ID: 8780406
[TBL] [Abstract][Full Text] [Related]
18. An experimental model system for HIV-1-induced brain injury.
Gendelman HE; Genis P; Jett M; Zhai QH; Nottet HS
Adv Neuroimmunol; 1994; 4(3):189-93. PubMed ID: 7874386
[TBL] [Abstract][Full Text] [Related]
19. Calcium channel antagonists and human immunodeficiency virus coat protein-mediated neuronal injury.
Lipton SA
Ann Neurol; 1991 Jul; 30(1):110-4. PubMed ID: 1656845
[TBL] [Abstract][Full Text] [Related]
20. EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-gamma: role of JAK/STAT1 signaling and implications for HIV-associated dementia.
Giunta B; Obregon D; Hou H; Zeng J; Sun N; Nikolic V; Ehrhart J; Shytle D; Fernandez F; Tan J
Brain Res; 2006 Dec; 1123(1):216-225. PubMed ID: 17078933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
